Puma Biotechnology (PBYI) EPS (Basic) (2017 - 2025)
Historic EPS (Basic) for Puma Biotechnology (PBYI) over the last 9 years, with Q3 2025 value amounting to $0.18.
- Puma Biotechnology's EPS (Basic) fell 5609.76% to $0.18 in Q3 2025 from the same period last year, while for Sep 2025 it was $0.75, marking a year-over-year increase of 5625.0%. This contributed to the annual value of $0.48 for FY2024, which is 368.48% up from last year.
- According to the latest figures from Q3 2025, Puma Biotechnology's EPS (Basic) is $0.18, which was down 5609.76% from $0.12 recorded in Q2 2025.
- Over the past 5 years, Puma Biotechnology's EPS (Basic) peaked at $0.41 during Q1 2021, and registered a low of -$1.09 during Q3 2021.
- For the 5-year period, Puma Biotechnology's EPS (Basic) averaged around $0.03, with its median value being $0.06 (2025).
- As far as peak fluctuations go, Puma Biotechnology's EPS (Basic) skyrocketed by 130000.0% in 2023, and later tumbled by 43333.33% in 2024.
- Puma Biotechnology's EPS (Basic) (Quarter) stood at $0.1 in 2021, then plummeted by 225.49% to -$0.13 in 2022, then soared by 307.2% to $0.26 in 2023, then decreased by 3.31% to $0.25 in 2024, then fell by 28.4% to $0.18 in 2025.
- Its EPS (Basic) was $0.18 in Q3 2025, compared to $0.12 in Q2 2025 and $0.06 in Q1 2025.